Helixmith Co

Helixmith Co P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Helixmith Co (084990.KQ) as of Oct 21, 2026 is -59.27. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -24.46 — a change of 142.34% (lower).

P/CF

-59.27

YoY

142.34%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Helixmith Co is 2025 -59.27 . P/CF (Price-to-Cash-Flow Ratio) of Helixmith Co was 2024 -24.46 . It decreases by 142.34% lower compared to the previous year.

The Helixmith Co P/CF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/CF
Date
P/CF
Jan 1, 2018
-30.39 KRW
Jan 1, 2019
-9.96 KRW
Jan 1, 2020
-8.52 KRW
Jan 1, 2021
-10.71 KRW
Jan 1, 2022
-10.04 KRW
Jan 1, 2023
-15.80 KRW
Jan 1, 2024
-24.46 KRW
Jan 1, 2025
-59.27 KRW
The Helixmith Co P/CF history
YEARP/CFYoY
-59.27+142.34%
-24.46+54.85%
-15.80+57.38%
-10.04-6.32%
-10.71+25.80%
-8.52-14.46%
-9.96-67.23%
-30.39-80.75%
-157.84-5.31%
-166.69-144.52%
374.43-84.86%
2,473.66—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Helixmith Co Stock analysis

What does Helixmith Co do? Helixmith Co., Ltd. generates revenue through its Natural Products Business segment, which develops and sells raw materials for functional materials and health functional foods under brands like Alex, Murphine, and Nimosin. The New Biopharmaceutical Business segment focuses on developing treatments for diabetic neuropathy, diabetic ischemic foot ulcer, amyotrophic lateral sclerosis, ischemic heart disease, and anticancer therapies. Customers include companies in the health and pharmaceutical sectors seeking natural ingredients and specialized medical treatments. The company serves two distinct market segments: one for natural product raw materials and another for advanced biopharmaceutical solutions. The Natural Products Business segment targets clients requiring raw materials for functional materials and health functional foods, leveraging branded products Alex, Murphine, and Nimosin. The New Biopharmaceutical Business segment caters to healthcare providers and pharmaceutical firms developing treatments for specific medical conditions, including diabetic neuropathy, diabetic ischemic foot ulcer, amyotrophic lateral sclerosis, ischemic heart disease, and anticancer applications. Both segments operate within the broader health and biotechnology industries, with the company's revenue streams derived from product sales across these specialized markets. Helixmith Co., Ltd. monetizes its research and development efforts through the commercialization of natural substance-based raw materials and biopharmaceutical treatments. The company's product portfolio includes Alex, Murphine, and Nimosin for the natural products market, while its biopharmaceutical segment offers treatments for diabetic neuropathy, diabetic ischemic foot ulcer, amyotrophic lateral sclerosis, ischemic heart disease, and anticancer conditions. Revenue is generated from direct sales to businesses in the health, functional food, and pharmaceutical sectors, with no mention of additional revenue streams such as licensing or partnerships. Helixmith Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Helixmith Co stock

P/CF (Price-to-Cash-Flow Ratio) of Helixmith Co is -59.27 in 2025.

P/CF (Price-to-Cash-Flow Ratio) of Helixmith Co changed from -24.46 to -59.27, representing a 142.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Helixmith Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Helixmith Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Helixmith Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Helixmith Co